1. Abramova E.B., Astakhova T.M., Erokhov P.A. et al. Multiple forms of the proteasomes and some approaches to their separation // Izvetsiya Rossiyskoy Akademii Nauk. Seriya Biologicheskaya. 2004. (2). 150–156. (in Russian)
2. Spirina L.V., Kondakova I.V., Choinzonov E.L. et al. Activity and subunit composition of proteasomes in head and cervical squamous cell carcinomas // Bull. Exp. Biol. Med. 2010. 149. (1). 82–85. (in Russian)
3. Spirina L.V., Bochkareva N.V., Kondakova I.V. et al Regulation of insulin-like growth NF-κB proteasome system in endometrial cancer // Mol. Biol. 2012. 46. (3). 407–413. (in Russian)
4. Arlt A., Bauer I., Schafmayer C. et al. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) // Oncogene. 2009. 28. 3983–3996.
5. Baud V., Derudder E. Control of NF-kB activity by proteolysis // Curr. Top. Microbiol. Immunol. 2011. 349. 97–114.
6. Ben-Shahar S., Komlosh A., Nadav E. et al. 26S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate // J. Biol. Chem. 1999. 274. 21963–21972.
7. Chen C., Seth A.K., Aplin A.E. Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer // Mol. Cancer Res. 2006. 4. 695–707.
8. Chen Z., Ricker J.L., Malhotra P.S. et al. Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms // Mol. Cancer Ther. 2008. 7. (7). 1949–1960.
9. Conner J.R., Smirnova I.I., Moseman A.P. et al. IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-kB p50 // Proc. Natl. Acad. Sci. USA. 2010. 107. (25). 11477–11482.
10. Goldberg A.L. Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy // Biochem. Soc. Trans. 2007. 35. 12–17.
11. Goll D.E., Thompson V.F., Li H. et al. The calpain system // Physiol. Rev. 2002. 83. 731–801.
12. Hensley S.E., Zanker D., Dolan B.P. et al. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses // J. Immunol. 2010. 184. (8). 4115–4122.
13. Hoffmann A., Baltimore D. Circuitry of nuclear factor kappaB signaling // Immunol. Rev. 2006. 210. 171–186.
14. Jiang L.Z., Wang P., Deng B. et al. Overexpression of Forkhead Box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis // Hum. Pathol. 2011. 42. (8). 1185–1193.
15. Juvekar A., Manna S., Ramaswami S. et al. Bortezomib induces nuclear translocation of IkBα resulting in gene-specific suppression of NF-kB-dependent transcription and induction of apoptosis in CTCL // Mol. Cancer Res. 2011. 9. (2). 183–194.
16. Klatte T., Seligson D.B., Riggs S.B. et al. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma // Clin. Cancer Res. 2007. 13. 7388–7393.
17. Li C., Li R., Grandis J. R. et al. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells //Mol. Cancer Ther. 2008. 7. (6). 1647–1655.
18. Li C., Chen S., Yue P. et al. Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkB(a) degradation // J. Biol. Chem. 2010. 285. (21). 16096–16104.
19. Liang X., Yang D., Hu J. et al. Hypoxia inducible factor-1a expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma // Anticancer Res. 2008. 28. 1659–1666.
20. Linder C., Linder S., Munck-Wikland E. et al. Evaluation of tissue and serum VEGF in patients with head and neck carcinoma // Angiogenesis. 1999. 2. 365–372.
21. Lowry O., Rosebrough W., Farr A., Randall R. Protein measurement with folin phenol reagent // J. Biol. Chem. 1951. 193. 265–275.
22. Moorthy A.K., Savinova O.V., Ho J.Q. et al. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner // EMBO J. 2006. 25. (9). 1945–1956.
23. Reichart J., Welter C., Mitschele T. et al. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin // J. Pathol. 2003. 199. (4). 509–516.
24. Ridge J.A., Glisson B.S., Lango M.N. et al. Head and neck tumors // Cancer management: 14th edition. http://www.cancernetwork.com/cancer-management/head-and-neck/article/10165/1802498
25. Sandmann S., Prenzel F., Shaw L. et al. Activity profile of calpains I and II in chronically infarcted rat myocardium-influence of the calpain inhibitor CAL 9961 // Br. J. Pharmacol. 2002. 135. (8). 1951–1958.
26. Schmitz M.L., Bacher S., Kracht M. IkB-independent control of NF-kB activity by modulatory phosphorylations // Trends Biochem. Sci. 2001. 26. 186–190.
27. Spirina L.V., Yunusova N.V., Kolomiets L.A. et al. Association of growth factors, HIF-1 and NF-kB expression with proteasomes in endometrial cancer // Mol. Biol. Rep. 2012. 39. (9). 8655–8662.
28. Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1a by NF-kB // J. Biochem. 2008. 412 (3). 477–484.
29. Voutsadakis I.A. Pathogenesis of colorectal carcinoma and therapeutic implications: the role of the ubiquitin-proteasome system and Cox-2 // J. Cell. Mol. Med. 2007. 11(2). 252–337.
30. Yan M., Xu Q., Zhang P. et al. Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma // BMC Cancer. 2010. 10. 437.
31. Yue C.X., Ma J., Zhou H.J. The effect of RhoA and proteasome inhibitor MG132 on angiogenesis in tumors // Sichuan Da Xue Xue Bao Yi Xue Ban. 2011. 42. (4). 445–501.
About Authors (Correspondence):
Choinzonov E.L. – doctor of medical sciences, professor, academician of RAMS, director, e-mail: nii@oncology.tomsk.ru
Spirina L.V. – candidate of medical sciences, senior researcher of laboratory of tumor biology, e-mail: spirinalv@oncology.tomsk.ru
Kondakova I.V. – doctor of medical sciences, professor, head of laboratory of tumor biochemistry, e-mail: kondakova@oncology.tomsk.ru
Chizhevskaya S.Yu. – candidate of medical sciences, senior researcher of head and neck cancer department, e-mail: nii@oncology.tomsk.ru
Shishkin D.A. – candidate of medical sciences, senior researcher of head and neck cancer department, e-mail: niio@sibmail.com
Kulbakin D.E. – junior researcher of head and neck cancer department, e-mail: nii@oncology.tomsk.ru
